SGHT

Sight Sciences, Inc.
NasdaqGSUSDEQUITY Healthcare DELAYED
Last price
8.26
▲ 0.11 (1.35%)
MARKET ·

Price

Open
8.25
Prev close
8.15
Day high
8.35
Day low
8.05
Volume
171.42K
Market cap
$455.03M
P/E (TTM)
52W range
3.19 – 9.24

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+1.47% +2.8%
1M
+75.74% +72.0%
3M
+60.70% +57.6%
6M
+52.96% +41.9%
YTD
+4.16% -8.1%
1Y
+102.95% +83.0%
3Y
+8.97% -65.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported
Market cap$455.03M
Enterprise value$417.25M
Revenue (TTM)$83.38M
Gross profit$73.34M
EBITDA$-19.26M
Net income$-29.76M
EPS (TTM)$-0.56
Free cash flow$-8.61M
Total cash$79.75M
Total debt$41.97M
Book value / share$0.97
Shares outstanding55.09M
Float35.59M
Short % of float2.06%
Dividend yield
Beta (5Y)2.42

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E-19.11
PEG ratio
Price / sales
Price / book8.54
EV / revenue5.00
EV / EBITDA-21.66
Gross margin87.96%
Operating margin-16.62%
Profit margin-35.69%
Return on equity-48.42%
Return on assets-10.84%
Debt / equity79.36
Current ratio4.95
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

Annual · as reported
Last 4 fiscal years
Line item2025202420232022
Total revenue$77.36M$79.87M$81.06M$71.33M
Cost of revenue$0$0$0$0
Gross profit$0$0$0$0
R&D
SG&A
Operating income
Pre-tax income
Tax provision$0$0$0$0
Net income-$38.43M-$51.51M-$55.55M-$86.24M
EBIT$0$0$0$0

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -0.14-0.08 +42.9%
Mar 2026 -0.20-0.24 -18.0%
Dec 2025 -0.14-0.08 +42.9%
Sep 2025 -0.26-0.16 +38.6%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter -0.13 5 $23.55M +18.3%
Next quarter -0.13 5 $23.71M +16.3%
Current year -0.49 5 $90.35M +16.8%
Next year -0.43 5 $101.07M +11.9%

Analyst targets & ownership

Account required
Mean target$9.00
High target$12.00
Low target$8.00
Implied upside8.96%
Analyst count5
ConsensusBUY
Strong buy / Buy1 / 4
Hold2
Sell / Strong sell0 / 0
Held by insiders20.06%
Held by institutions52.39%
Institutions holding155
Free account required

Price targets, consensus spread, insider and institutional ownership.

Insider net activity

6m · Form 4 rollup
Net shares
+175.87K
Net buying
Buy transactions
8
358.49K shares
Sell transactions
13
182.63K shares
Net transactions
+21
Buys less sells
Sell : buy shares
0.5 : 1
Mixed
Insider-held shares
11.05M
Total on file
Bought 358.49KSold 182.63K

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 10, 26
RASHID KASHIF
Officer
STOCK 181.82K $0 Direct
Jul 6, 26
HAYDEN JEREMY BRAGG
Officer
SELL 12.73K $70.13K Direct
Jul 6, 26
BADAWI DAVID
Chief Technology Officer
SELL 7.42K $40.86K Direct
Jul 2, 26
BAUERLEIN ALISON
Chief Operating Officer
SELL 24.18K $129.63K Direct
Jul 2, 26
RODBERG JAMES
Chief Financial Officer
SELL 6.90K $36.99K Direct
Jul 1, 26
TAYLOR BRENTON
Officer
SELL 2.83K $15.33K Direct
Jul 1, 26
BADAWI PAUL
Chief Executive Officer
SELL 28.68K $155.47K Direct
Jun 10, 26
ENCRANTZ STAFFAN
Director and Beneficial Owner of more than 10% of a Class of Security
BUY 14.10K $68.79K Direct
Jun 4, 26
FOUNTAIN TAMARA R.
Director
STOCK 28.26K $0 Direct
Jun 4, 26
MAZZACCO CATHERINE
Director
STOCK 28.26K $0 Direct
Jun 4, 26
BURBACH GERHARD F
Director
STOCK 28.26K $0 Direct
Jun 4, 26
ZURBAY DONALD J
Director
STOCK 28.26K $0 Direct
Jun 4, 26
ENCRANTZ STAFFAN
Director and Beneficial Owner of more than 10% of a Class of Security
STOCK 28.26K $0 Direct
May 18, 26
BAUERLEIN ALISON
Chief Operating Officer
SELL 12.73K $65.17K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BADAWI DAVID
Chief Technology Officer 1.98M Sale
BADAWI PAUL
Chief Executive Officer 6.12M Sale
BAUERLEIN ALISON
Chief Operating Officer 664.71K Sale
ENCRANTZ STAFFAN
Director and Beneficial Owner of more than 10% of a Class of Security 7.15M Purchase
HAYDEN JEREMY BRAGG
Officer 357.04K Sale
LINK MATTHEW
Officer 832.29K Sale
PARK SAM BOONG
Chief Operating Officer 254.83K Sale
RODBERG JAMES
Chief Financial Officer 224.04K Sale
TAYLOR BRENTON
Officer 264.98K Sale
ZURBAY DONALD J
Director 193.61K Stock Award(Grant)

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
8.15
+1.31% from price
SMA 20
6.95
+18.77% from price
SMA 50
5.92
+39.52% from price
SMA 100
5.16
+59.98% from price
SMA 200
5.75
+43.73% from price
EMA 12
7.77
+6.25% from price
EMA 26
6.96
+18.74% from price
EMA 50
6.24
+32.32% from price
RSI (14)
74.7
Overbought
MACD (12,26,9)
0.82
Hist 0.09
ATR (14)
0.55
6.69% of price
Realised vol 30D
84.4%
Annualised
Bollinger upper
9.61
20, 2σ
Bollinger lower
4.29
20, 2σ
50 / 200 cross
Golden
5.92 vs 5.75
Trend bias
Above 200
+43.73%

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.82
More volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
84.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-61.9%
Peak to trough
Max drawdown 5Y
-96.6%
Peak to trough
ATR 14
0.55
6.69% of price
Beta (reported)
2.42
5Y monthly, from filing

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.00
Positioning, not flow
Max pain
5.00
-39.5% from spot
ATM implied vol
154.7%
Nearest strike to spot
Skew (10% OTM)
Call volume
340
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
10.00
1.53K contracts
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 8.26
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.